SYMTUZA 800-150-200-10 MG TAB

Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide
$152.9410per EA

Strength

150; 800; 200; 10 mg/1; mg/1; mg/1; mg/1

NDC

59676080030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA210455

On Market Since

7/17/2018

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A Inhibitors
HIV Protease Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Multidrug and Toxin Extrusion Transporter 1 Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides
Nucleosides
Organic Anion Transporting Polypeptide 1B1 Inhibitors
Organic Anion Transporting Polypeptide 1B3 Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

+0.2%

1Y

+0.4%

3Y

+3.0%

5Y

+16.4%

All

+37.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.